Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12606000226505
Ethics application status
Approved
Date submitted
1/06/2006
Date registered
5/06/2006
Date last updated
5/06/2006
Type of registration
Retrospectively registered

Titles & IDs
Public title
Manual therapies for osteoarthritis: A pilot study
Scientific title
Massage and joint mobilisation for improving quality of life in people with osteoarthritis: A pilot study
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Osteoarthritis 1204 0
Condition category
Condition code
Musculoskeletal 1289 1289 0 0
Osteoarthritis

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Intervention groups: massage adjunct to usual care, joint mobilisation adjunct to usual care

Duration: 10 weeks (one Victorian school term)
Frequency of intervention: one session (approx 40 minutes) per week
Three group comparison of the effects of usual care with 2 types of manual therapy adjunctive to usual care on the health-related quality of life of people with osteoarthritis.
Intervention code [1] 1056 0
Treatment: Other
Comparator / control treatment
Control group: usual care
Control group
Active

Outcomes
Primary outcome [1] 1754 0
Pain: measured using short-form McGill Pain Questionnaire, returns scores for sensory pain, affective pain, total pain, present pain index, and visual analogue pain scale.

Primary timepoint week 9 of 10 week intervention.
Timepoint [1] 1754 0
Measures taken at baseline, week 5, week 9
Primary outcome [2] 1755 0
Arthritis-specific quality of life, measured using the Arthritis Impact Measurement Scales version 2 (AIMS2).

Primary timepoint week 9 of 10 week intervention.
Timepoint [2] 1755 0
Measures taken at baseline, week 5, week 10
Secondary outcome [1] 3103 0
General health-related quality of life.
Timepoint [1] 3103 0
Measured using the Medical Outcomes Study 36-Item health survey (SF-36).
Secondary outcome [2] 3104 0
Returns scores on 9 quality of life domains.
Timepoint [2] 3104 0
Secondary timepoints, baseline, week 5 of 10 week intervention. (Measures taken at baseline, week 5, week 9).

Eligibility
Key inclusion criteria
Able to walk 20 metres unaided, able to dress / undress self, able to read / write in English.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Substantive co-morbidity, development / diagnosis of co-morbidity during intervention period.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation is not concealed
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
random number table
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Pilot study of small sample size - results intpretted in terms of clinically meaningful effect sizes rather than statistical significance.
Phase
Phase 1
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
1/02/2003
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
19
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 1415 0
University
Name [1] 1415 0
Victoria University
Country [1] 1415 0
Australia
Primary sponsor type
University
Name
Victoria University
Address
Country
Australia
Secondary sponsor category [1] 1241 0
None
Name [1] 1241 0
nil
Address [1] 1241 0
Country [1] 1241 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 2771 0
Victoria University
Ethics committee address [1] 2771 0
Ethics committee country [1] 2771 0
Australia
Date submitted for ethics approval [1] 2771 0
Approval date [1] 2771 0
27/02/2003
Ethics approval number [1] 2771 0
HRETH.FHD.045/01

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 36093 0
Address 36093 0
Country 36093 0
Phone 36093 0
Fax 36093 0
Email 36093 0
Contact person for public queries
Name 10245 0
Dr Melainie Cameron
Address 10245 0
Victoria University
School of HMRP
PO Box 14428
Melbourne MC 8001
Country 10245 0
Australia
Phone 10245 0
+61 3 9919 4287
Fax 10245 0
+61 3 9919 4891
Email 10245 0
Melainie.Cameron@vu.edu.au
Contact person for scientific queries
Name 1173 0
Dr Melainie Cameron
Address 1173 0
Victoria University
School of HMRP
PO Box 14428
Melbourne MC 8001
Country 1173 0
Australia
Phone 1173 0
+61 3 9919 4287
Fax 1173 0
+61 3 9919 4891
Email 1173 0
Melainie.Cameron@vu.edu.au

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.